Prior to obtaining access to the material and information contained on this website, please read carefully the following important information. Please note that the disclaimer set out below may be altered or updated. You should read it in full each time you visit the site.
IF YOU ACCESS THIS SECTION OF THE WEBSITE OR ANY OF THE INFORMATION IT CONTAINS, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET OUT BELOW.
IF YOU DO NOT AGREE TO THE TERMS AND CONDITIONS, DO NOT ACCESS THIS SITE OR ANY OF ITS INFORMATION.
THE MATERIAL AND INFORMATION CONTAINED ON THIS WEBSITE IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE, TRANSMISSION, DISTRIBUTION, OR FORWARDING DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.
In accessing this portion of the website you understand that these materials are solely for information purposes and do not constitute an offer to sell or issue, or the solicitation of an offer to buy, acquire or subscribe for, any securities of Ryvu Therapeutics Spółka Akcyjna (the “Company”) in any jurisdiction in which such an offer or solicitation is unlawful. The material and information contained on this website has not been approved by any supervising authority or stock exchange. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.
The material and information contained on this website is by no means intended, whether directly or indirectly, to promote the offering, subscription or purchase of the securities of the Company referred to in this material and does not represent advertisement or promotional material prepared or published by the Company for the purpose of promoting its securities or their offering or subscription or for the purpose of encouraging an investor, whether directly or indirectly, to subscribe for or acquire the securities in the Company.
The securities referred to in these materials have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold, pledged, taken up, resold, transferred or delivered, directly or indirectly, in or into the United States absent registration under the Securities Act, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. The securities referred to in these materials have not been approved, disapproved or recommended by the U.S. Securities and Exchange Commission, any state securities commission in the United States or any other U.S. regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the offering of the securities of the Company. Subject to certain exceptions, the securities referred to herein may not be offered or sold in the United States, Australia, Canada, Japan, South Africa or to, or for the account or benefit of, any national, resident or citizen of the United States, Australia, Canada, Japan, the Republic of South Africa.
Accessing and viewing these materials in breach of the above disclaimer may constitute a breach of laws governing the trading in securities, in particular in Poland and the United States of America.
Click as appropriate below:
I ACKNOWLEDGE AND CONFIRM THAT I HAVE READ, UNDERSTOOD AND ACCEPT THE ABOVE TERMS AND CONDITIONS AND HEREBY CONFIRM THAT I AM NOT RESIDENT OR LOCATED IN THE UNITED STATES, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR AUSTRALIA AND NOT RESIDENT OR LOCATED IN ANY OTHER JURISDICTION WHERE TO ACCESS THE INFORMATION CONTAINED ON THIS WEBSITE WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF, OR REQUIRE REGISTRATION IN, SUCH JURISDICTION.